• Mashima, T., Iwasaki, R., Kawata, N., Kawakami, R., Kumagai, K., Migita, T., Sano, T., Yamaguchi, K. and Seimiya, H.
  In silico chemical screening identifies epidermal growth factor receptor as a therapeutic target of drug-tolerant CD44v9-positive gastric cancer cells.
  Br. J. Cancer., in press (2019)
• Udagawa, C., Horinouchi, H., Shiraishi, K., Kohno, T., Okusaka, T., Ueno, H., Tamura, K., Ohe, Y. and Zembutsu, H.
  Whole genome sequencing to identify predictive markers for the risk of drug-induced interstitial lung disease.
  PLoS One, in press (2019)
• Hara-Nakano, M., Udagawa, C., Shimo, A., Kojima, Y., Yoshie, R., Zaha, H., Abe, N., Tokiwa, M., Uensoko, M., Tamura, K., Shimoi , T., Yoshida, M., Yoshida, T., Sakamoto, H., Kato, K., Mushiroda, T., Tsugawa, K. and Zembutsu, H.
  A genome-wide association study identifies five novel genetic markers for trastuzumab-induced cardiotoxicity in Japanese population.
  Biol. Pharm. Bull., in press (2019)
• Katayama, R., Gong, B., Togashi, N., Miyamoto, M., Kiga, M., Iwasaki, S., Kamai, Y., Tominaga, Y., Takeda, Y., Kagoshima, Y., Shimizu, Y., Seto, Y., Oh-hara, T., Koike, S., Nakao, N., Hanazawa, H., Watanabe, K., Yoda, S., Yanagitani, N., Hata, A. N., Shaw, A. T., Nishio, M., Fujita, N. and Isoyama, T.
  The new-generation selective ROS1/NTRK Inhibitor DS-6051b overcomes crizotinib resistant ROS1-G2032R mutation in preclinical models
  Nat. Commun., in press (2019)
  
  ニュースリリース文章はこちら
  
• Suzuki, Y., Kobayashi, K., Wakisaka, Y., Deng, D., Tanaka, S., Huang, C. J., Lei, C., Liu, H., Fujiwaki, Y., lee, S., isozaki, A., Kasai, Y., hayakawa, T., Sakuma, S., Arai, F., Koizumi, K., Tezuka, H., Inaba, M., hiraki, K., Ito, T., Hase, M., Matsusaka, S., Shiba, K., Suga, K., Nishikawa, M., Jona, M., Yatomi, Y., Yaxiaer, Y., Tanaka, Y., Sugimura, T., Nitta, N., Goda, K. and Yasuyuki, O.
  Label-free chemical imaging flow cytometry by high-speed multicolor stimulated Raman scattering.
  Proc. Natl. Acad. Sci. U. S. A., in press (2019)

more